from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1326c/glgB

LFCtreatmentdescriptionclass of inhibitor

-1.154

Amikacinug/mL Amikacintranslation

-2.085

Cap5-10ug/mL Capreomycintranslation

-1.525

Rox10-50 ug/mL Roxithromycintranslation

-0.254

SM2-5 ug/mL Streptomycintranslation

-2.745

Tet5-10 ug/mL Tetracyclinetranslation

-0.085

Rif0.2-5ug/mL Rifampicintranscription

-1.061

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.670

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.344

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.128

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.773

Clofazimine10-13 ug/mL Clofaziminerespiration

0.674

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.424

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.734

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.336

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.379

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.028

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.490

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.451

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.100

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.654

KCN5-20 ug/mL Potassium cyaniderespiration

-0.128

NaN30.2-2 mM Sodium aziderespiration

-1.011

Nigericin50 uM Nigericinrespiration

0.524

TRC10-150 ug/mL Triclosanrespiration

-0.269

TRZ10-25 ug/mL Thioridazinerespiration

-1.070

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.306

menadione6-10 ug/mL Menadionerespiration

-0.129

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.072

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.234

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.630

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.561

NRP_1Non-replicating persistence stage 1dosRassociated

-0.079

Amp0.2mg/mL AmpicillincellWall

-0.567

Cephalexin20-100 ug/mL CephalexincellWall

0.263

Cerulenin0.32-5 ug/mL CerulenincellWall

0.094

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.039

EMB10-20 ug/mL EthambutolcellWall

-0.013

Eta12-40 ug/mL EthionamidecellWall

-0.248

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.011

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.606

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.615

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.220

BZA0.12 mg/mL BenzamidearomaticAmides

0.561

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.992

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.414

H2O24 mM hydrogen peroxideDNAdamaging

-0.077

Levo10 ug/mL LevofloxacinDNAdamaging

0.382

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.138

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.393

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.340

UVUV-irradiationDNAdamaging

-0.961

ARP41-4 ug/mL Antitubercular compound ARP4?

0.015

Antimycin12.5-50 ug/mL Antimycin A?

-0.537

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.478

PA_110-50 ug/mL Antitubercular compound PA-1?

0.106

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.162

PA8240.2-2 ug/mL PA-824?

0.919

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.906

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.158

Verapamil50 uM Verapamil?

-1.442

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.145

methoxatin10-20 ug/mL Methoxatin?